[HTML][HTML] Tumoral heterogeneity in neuroblastoma
RL Gomez, S Ibragimova, R Ramachandran… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Neuroblastoma is a solid, neuroendocrine tumor with divergent clinical behavior ranging
from asymptomatic to fatal. The diverse clinical presentations of neuroblastoma are directly …
from asymptomatic to fatal. The diverse clinical presentations of neuroblastoma are directly …
Biological and genetic features of neuroblastoma and their clinical importance
N Aygun - Current pediatric reviews, 2018 - ingentaconnect.com
Neuroblastoma derived from primitive cells of the sympathetic nervous system typically
develops in the adrenal medulla or paraspinal ganglia. Neuroblastoma usually occurs …
develops in the adrenal medulla or paraspinal ganglia. Neuroblastoma usually occurs …
Hypoxia-induced HIF1α activation regulates small extracellular vesicle release in human embryonic kidney cells
A Muñiz-García, M Romero, JM Falcόn-Perez… - Scientific Reports, 2022 - nature.com
Extracellular vesicles (EVs) are membrane enclosures released by eukaryotic cells that
carry bioactive molecules and serve to modulate biological responses in recipient cells. Both …
carry bioactive molecules and serve to modulate biological responses in recipient cells. Both …
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma
Adverse prognosis in Ewing sarcoma (ES) is associated with the presence of metastases,
particularly in bone, tumor hypoxia and chromosomal instability (CIN). Yet, a mechanistic …
particularly in bone, tumor hypoxia and chromosomal instability (CIN). Yet, a mechanistic …
C1GalT1 expression reciprocally controls tumour cell-cell and tumour-macrophage interactions mediated by galectin-3 and MGL with double impact on cancer …
Although most cell membrane proteins are modified by glycosylation, our understanding of
the role and actions of protein glycosylation is still very limited. β1, 3galactosyltransferase …
the role and actions of protein glycosylation is still very limited. β1, 3galactosyltransferase …
Hypoxia predicts poor prognosis in neuroblastoma patients and associates with biological mechanisms involved in telomerase activation and tumor microenvironment …
D Cangelosi, M Morini, N Zanardi, AR Sementa… - Cancers, 2020 - mdpi.com
The biological and clinical heterogeneity of neuroblastoma (NB) demands novel biomarkers
and therapeutic targets in order to drive the most appropriate treatment for each patient …
and therapeutic targets in order to drive the most appropriate treatment for each patient …
Recent advances in salivary cancer diagnostics enabled by biosensors and bioelectronics
There is a high demand for a non-invasive, rapid, and highly accurate tool for disease
diagnostics. Recently, saliva based diagnostics for the detection of specific biomarkers has …
diagnostics. Recently, saliva based diagnostics for the detection of specific biomarkers has …
Extracellular vesicles from subjects with COPD modulate cancer initiating cells phenotype through HIF-1α shuttling
I Petraroia, P Ghidotti, G Bertolini, F Pontis, L Roz… - Cell Death & …, 2023 - nature.com
Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer development.
COPD induces activation of hypoxia-induced signaling, causing remodeling of surrounding …
COPD induces activation of hypoxia-induced signaling, causing remodeling of surrounding …
Histotripsy induces apoptosis and reduces hypoxia in a neuroblastoma xenograft model
I Iwanicki, LL Wu, F Flores-Guzman… - International Journal …, 2023 - Taylor & Francis
Background Neuroblastoma (NB) is the most common extracranial solid tumor of childhood,
and high-risk disease is resistant to intensive treatment. Histotripsy is a focused ultrasound …
and high-risk disease is resistant to intensive treatment. Histotripsy is a focused ultrasound …
Optimising the chick chorioallantoic membrane xenograft model of neuroblastoma for drug delivery
Background Neuroblastoma is a paediatric cancer that despite multimodal therapy still has a
poor outcome for many patients with high risk tumours. Retinoic acid (RA) promotes …
poor outcome for many patients with high risk tumours. Retinoic acid (RA) promotes …